Company

C3® International, Inc. has been formed to play a leadership role in the emerging medical cannabis health sector.

We are committed to improving lives with Idrasil™.

Company Snapshot

  • Company Name: C3® International, Inc.
  • Year Founded: 2010
  • Stage of Development: Series A
  • Financial Advisors: TheCodeCorp
  • Research Sector: Specialty Pharmaceutical
  • Ownership: Private
  • C3® Executive Staff

    Chairman & CEO
    Steele Clarke Smith III

    Co-Founder of C3®


    In 1992, Mr. Smith founded U.S. Vinyl Inc., creator of I.D. SAFE, a U.S. Registered Trademark #75-212338 held by U.S. Vinyl which also holds two other U.S Patents, Patent #5,700,036, Patent #8,656,052. Mr. Smith’s creative marketing strategies revolutionized the promotional projects industry with the “manufacturer-direct” concept.

    In 1988, Mr. Smith studied English at Cambridge University, England, then the University of San Francisco in their “3 and 3” program; three years of undergraduate work and three years of law school; 1989 transferred to USC English Dept.; 1992 Graduated USC, BA. 1990 President of Phi Gamma Delta, National Fraternity, USC; Treasurer USC Cycling Team; volunteer AIDS Project LA.

    In 1997, he was a semifinalist of Inc. Magazine Market Masters Award; 2004 nominated for a TOYA (Ten Outstanding Young Americans); 2006 awarded Outstanding Young Californian of US Jr. Chamber of Commerce; 2005 founded C3, California Compassionate Caregivers; 2005 founded Orange County Chapter of American’s for Safe Access; 2009 founded Greater Orange County Collective Alliance.


    Steele's LinkedIn
    Steele Smith on ResearchGate

    President
    Theresa Ann Smith

    Co-Founder of C3®


    Co-founder of C3®, California Compassionate Caregivers, in 2005 an Orange County Chapter of American’s for Safe Access; 2009 founded Greater Orange County Collective Alliance and in 2009 co-founded National ASA; 2009 founding member of C3®.

    Theresa Ann Smith is a National advocate for safe patient access to holistic medicine, specifically Cannabis. She is the founding Vice President of C3® International, Inc., the manufacturer of the patent(s)-pending Idrasil™, the world's first naturally derived, non-synthetic, pharmaceutical grade Cannabis Tablet, 12.5mg, 25mg, 100mg.

    Mrs. Smith along with her husband Steele C. Smith, III, Chairman, are pioneers of cannabis collectives under California's Compassionate Use Act of 1996. Founding California Compassionate Caregivers (C3®) Cannabis Collective, in 2006.

    Ms. Smith served 7 years in administrative management at Chapman University for the Vice Provost and the Dean of Graduate Studies functioned as Scribe for seven Accreditation Committees that was instrumental in the College receiving National Accreditation to become a University. Co-managed and serving for 14 years as Director of Human Resources, Business Development and Customer Relations at U.S. Vinyl Inc. 2004 Chapman University majoring in Child Development with a Minor in English Literature.


    Theresa's LinkedIn

    Barb Nolta, Comptroller

    Untitled design (5)
    C3® Comptroller
    Barb's LinkedIn

    Leon Fleyshman, CFO

    Leon C3
    C3® Chief Financial Officer
    Leon's LinkedIn

    Dr. Stephen Goldner, JD, CSO

    C3® Chief Science Officer
    Dr. Goldner's LinkedIn

    Bruce McCullough, IT Security Director

    Bruce Mccullough 40 percent
    C3® IT Security Director
    Bruce's LinkedIn

    Christopher Knell, CIO

    C3® Chief Information Officer
    Christopher's LinkedIn

    Thomas Todd, COO

    C3® Chief Operating Officer
    Thomas's LinkedIn

    Chris Cota, CSP

    Untitled design (7)
    C3® Chief of Strategic Projects
    Chris' LinkedIn

    Edward Yang, PR

    Untitled design (20)
    C3® Public Relations Director
    Edward's LinkedIn

    Mohan Gupta

    Mohan Gupta 2
    C3® WebMaster
    Mohan's LinkedIn

    Jacques Goulet, CAO

    C3® Chief Agriculture Officer
    Jacques' LinkedIn

    Harry Nelson, Esq., BoA

    harry nelson no smile pic square
    C3® General Council
    Board of Advisors
    Harry's LinkedIn

    Larry Gill, Esq., BoA

    Larry Gill
    C3® Transactional Lawyer
    Board of Advisors
    Larry's LinkedIn

    P.W. McLaughlin, Esq.

    C3® Federal Law Counsel
    Patrick's LinkedIn

    Jonathan Buck, Esq.

    Johnathan Buck 2
    C3® Insurance Counsel
    Jonathan's LinkedIn

    Douglas Pettibone, Esq.

    Untitled design (14)
    Steele's Lawyer
    Douglas's LinkedIn

    Dennis Riff, M.D.

    dennis riff
    C3® Clinical Trials Director
    Dennis' LinkedIn

    Patrick McLaughlin, CRD

    C3® Clinical Research Director
    Patrick's LinkedIn

    Gregory Smith, M.D.

    C3® Education Director
    Dr. Smith's LinkedIn

    Dr. Steven Malen, MBA, BoA

    steven malen 200
    C3® Board of Advisors
    Steven's LinkedIn

    Kassim Osgood, BoA

    Kassim
    C3® Board Of Advisors
    Kassim's LinkedIn